Stakeholders Interviewed Primary interviews for this study involved: Manufacturers and suppliers in the market value chain Distributors, channel partners, and integrators End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market) Industry experts, technology specialists, consultants, and regulatory professionals Senior executives (CEOs, CTOs, VPs, Directors) and product managers Interview Process Interviews were conducted via: Structured and semi-structured questionnaires Telephonic and video interactions Email correspondences Expert consultation sessions Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation
Dihexa potential application in different clinical research settings Dihexa shows promise in treating Alzheimers disease by rescuing cognitive impairment and ameliorating neuronal loss in preclinical models
F.RaychaudhuriU.HsuS.BedlackR
Focus on Homocysteine Levels: Measuring homocysteine levels is often a more reliable indicator of potential health risks than MTHFR gene mutation testing alone
repurchase offers
Yes, glutathione is approved as an antioxidant